§ 1141a.21. Definitions.
The following words and terms, when used in this part, have the following meanings, unless the context clearly indicates otherwise:
ACRC—Academic clinical research center—An accredited medical school in this Commonwealth that operates or partners with an acute care hospital licensed and operating in this Commonwealth that has been approved and certified by the Department to enter into a contract with a clinical registrant.
Accreditation body—An organization which:(i) Certifies the competency, expertise and integrity of a laboratory and operates in conformance with the current version of International Organization Standard ISO/IEC 17011.
(ii) Determines a laboratory’s compliance with and conformance to the relevant standards established by the International Organization for Standardization, including ISO/IEC 17025.
(iii) Is a signatory to the International Accreditation Cooperation Mutual Recognition Arrangement for Testing.
(iv) Is not affiliated with a laboratory applicant for which it has or will issue a certificate of accreditation.
Accredited medical school—An institution that is:(i) Located in this Commonwealth.
(ii) Accredited by the Liaison Committee of Medical Education or the Commission on Osteopathic College Accreditation.
Act—The Medical Marijuana Act (35 P.S. § § 10231.101—10231.2110).
Acute care hospital—A facility having an organized medical staff that provides equipment and services primarily for inpatient medical care and other related services to persons who require definitive diagnosis or treatment, or both, for injury, illness, pregnancy or other disability and is licensed by the Department to operate as a hospital in this Commonwealth under the Health Care Facilities Act (35 P.S. § § 448.101—448.904b) and the regulations promulgated thereunder.
Added substance—An additional ingredient added to medical marijuana during or after processing that is present in the final product or any substance used to change the viscosity or consistency of a cannabinoid product.
Adult patient—A patient who is 18 years of age or older.
Adverse event—An injury resulting from the use of medical marijuana dispensed at a dispensary. An injury includes physical harm, mental harm or loss of function.
Adverse loss—A loss, discrepancy in inventory, diversion or theft of seeds, immature medical marijuana plants, medical marijuana plants, medical marijuana, medical marijuana products, funds or other property of a medical marijuana organization.
Advertising—The publication, dissemination, solicitation or circulation, for a fee, that is visual, oral, written or electronic to induce directly or indirectly an individual to patronize a particular dispensary, laboratory or practitioner, or to purchase particular medical marijuana products.
Applicant—Depending on the context the term may mean any of the following:(i) A person who wishes to submit or submits an application to the Department for a permit to operate as a grower/processor or dispensary, or both, under the act and this part.
(ii) A patient or a caregiver who submits an identification card application to the Department.
(A) The term includes a legal guardian or a parent who submits an application on behalf of a patient.
(B) The term does not include an individual under 21 years of age unless the Department has determined under section 507(a) of the act (35 P.S. § 10231.507(a)) that the individual should be permitted to serve as a caregiver.
(iii) A person who submits an application to the Department to become an approved laboratory, an ACRC or a clinical registrant.
Approved laboratory—A laboratory that has applied for, and received, the approval of the Department to identify, collect, handle and conduct tests on samples from a grower/processor and test samples from the Department used in the growing and processing of medical marijuana or dispensing of medical marijuana products as required by the act and this part.
CAS number—The unique numerical identifier assigned to every chemical substance by Chemical Abstracts Service, a division of the American Chemical Society.
CBC—Cannabichromene, CAS number 20675-51-8.
CBD—Cannabidiol, CAS number 13956-29-1.
CBDA—Cannabidiolic acid, CAS number 1244-58-2.
CBDV—Cannabidivarin, CAS number 24274-48-4.
CBG—Cannabigerol, CAS number 25654-31-3.
CBN—Cannabinol, CAS number 521-35-7.
Cannabinoids—The chemical compounds that are the active constituents of marijuana.
Caregiver—One of the following:(i) An individual designated by a patient to obtain on behalf of a patient, and provide to a patient, a medical marijuana product.
(ii) For a minor patient, an individual who meets the requirements in section 506(2) of the act (35 P.S. § 10231.506(2)).
(iii) Individuals designated in writing by an organization that provides hospice, palliative or home care services and who:
(A) Are employed by an organization licensed under the Health Care Facilities Act;
(B) Have significant responsibility for managing the health care and well-being of a patient; and
(C) Were designated by the organization to provide care to a patient who authorized the designation.
(iv) Individuals designated in writing by a residential facility, including a long-term care nursing facility, a skilled nursing facility, an assisted living facility, a personal care home, an independent long-term care facility or an intermediate care facility for individuals with intellectual disabilities who:
(A) Are licensed by the Department or the Department of Human Services;
(B) Have significant responsibility for managing the health care and well-being of the patient; and
(C) Were designated by the residential facility to provide care to a patient who authorized the designation.
Certificate of accreditation—A document issued by an accreditation body evidencing that a laboratory is in compliance with International Organization for Standardization Standard ISO/IEC 17025 or other standards relevant to the operation of laboratories conducting tests on medical marijuana, medical marijuana products and other items used in the growing and processing of medical marijuana or dispensing of medical marijuana products.
Certificate of analysis—A document that confirms that the test performed by an approved laboratory on a harvest batch, harvest lot, process lot, or sample for stability meets the testing requirements set forth by the Department.
Certified medical use—The acquisition, possession, use or transportation of medical marijuana products by a patient; or the acquisition, possession, delivery, transportation or administration of medical marijuana products by a caregiver, for use as part of the treatment of the patient’s serious medical condition, as authorized in a patient certification, including enabling the patient to tolerate treatment for the serious medical condition.
Certified registered nurse practitioner—The term as defined in section 2 of The Professional Nursing Law (63 P.S. § 212).
Chain of custody—The written procedures used by employees of an approved laboratory to record the possession and transfer of samples and test samples and the real-time documentation of actions taken from the time the samples and test samples are collected until the test of the sample or test sample is completed.
Change in control—The acquisition by a person or group of persons acting in concert of a controlling interest in an applicant or permittee either all at one time or over the span of a 12-consecutive-month period.
Change in ownership—The addition or removal of a principal, operator or financial backer or a change in control of a medical marijuana organization after the Department approves an initial permit application or a permit renewal application.
Clinical registrant—An entity that:(i) Holds a permit as both a grower/processor and a dispensary;
(ii) Has a contractual relationship with an ACRC under which the ACRC or its affiliate provides advice to the entity, regarding, among other areas, patient health and safety, medical applications and dispensing and management of controlled substances; and
(iii) Is approved by the Department.
Continuing care—Treating a patient, in the course of which the practitioner has completed a full assessment of the patient’s medical history and current medical condition, including a consultation with the patient.
Controlled substance—A drug, substance or immediate precursor included in Schedules I—V as listed in section 4 of The Controlled Substance, Drug, Device and Cosmetic Act (35 P.S. § 780-104).
Controlling interest—(i) For a publicly traded entity, voting rights that entitle a person to elect or appoint one or more of the members of the board of directors or other governing board or the ownership or beneficial holding of 5% or more of the securities of the publicly traded entity.
(ii) For a privately held entity, the ownership of any security in the entity.
D8—Delta 8 tetrahydrocannabinol, CAS number 5957-75-5.
De-identified data—A record retrieved from the electronic tracking system transmitted to an ACRC for medical marijuana research purposes after removal of all personal information that could identify a patient.
Department—The Department of Health of the Commonwealth.
Device—An object used, intended for use or designed for use in preparing, storing, ingesting, inhaling or otherwise introducing medical marijuana into the human body.
Disadvantaged business—The term as defined in 74 Pa.C.S. § 303(b) (relating to diverse business participation).
Dispensary—(i) A person who holds a permit issued by the Department to dispense medical marijuana products.
(ii) The term does not include a health care medical marijuana organization as defined under sections 1901—1908 of the act (35 P.S. § § 10231.1901—10231.1908).
Dispense—The activity of lawfully providing to a patient or caregiver medical marijuana products in a suitable container that is appropriately labeled for subsequent administration or use under a patient certification issued by a practitioner.
Diverse group—A disadvantaged business, minority-owned business, women-owned business, service-disabled veteran-owned small business or veteran-owned small business that has been certified by a third-party certifying organization.
Diverse participants—The term includes the following:(i) Individuals from diverse racial, ethnic and cultural backgrounds and communities.
(ii) Women.
(iii) Veterans.
(iv) Individuals with disabilities.
Diversity plan—A strategy that promotes or ensures participation by diverse groups in the management and operation of a medical marijuana organization through contracting and employment opportunities.
Electronic tracking system—An electronic seed-to-sale system approved by the Department that is utilized by:(i) A grower/processor to log, verify and monitor the receipt, use and sale of seeds, immature medical marijuana plants, medical marijuana plants, medical marijuana and medical marijuana products, the funds received by a grower/processor for the sale of seeds, immature medical marijuana plants, medical marijuana plants, medical marijuana and medical marijuana products to another medical marijuana organization, the disposal of medical marijuana waste and the recall of defective seeds, immature medical marijuana plants, medical marijuana plants, medical marijuana and medical marijuana products.
(ii) A dispensary to log, verify and monitor the receipt of medical marijuana product from a grower/processor, the verification of the validity of an identification card presented by a patient or caregiver, the dispensing of medical marijuana product to a patient or caregiver, the disposal of medical marijuana waste and the recall of defective medical marijuana products.
(iii) An approved laboratory to log, verify and monitor the receipt of samples and test samples for testing, the results of tests performed by the approved laboratory, and the disposal of tested and untested samples and test samples.
Employee—An individual who is hired for a wage, salary, fee or payment to perform work for an applicant or permittee.
Excipients—Solvents, chemicals or materials reported by a medical marijuana organization and approved by the Department for use in the processing of medical marijuana.
Facility—A structure and other appurtenances or improvements where a medical marijuana organization grows and processes or dispenses medical marijuana.
Family or household member—The term as defined in 23 Pa.C.S. § 6102 (relating to definitions).
Financial backer—An investor, mortgagee, bondholder, noteholder or other source of equity, capital or other assets other than a financial institution.
Financial institution—A bank, a National banking association, a bank and trust company, a trust company, a savings and loan association, a building and loan association, a mutual savings bank, a credit union or a savings bank.
Form of medical marijuana—The characteristics of the medical marijuana recommended or limited for a particular patient, including the method of consumption and any particular dosage, strain, variety and quantity or percentage of medical marijuana or particular active ingredient.
Fund—The Medical Marijuana Program Fund established in section 902 of the act (35 P.S. § 10231.902).
Grower/processor—(i) A person who holds a permit from the Department under the act to grow and process medical marijuana.
(ii) The term does not include a health care medical marijuana organization as defined under sections 1901—1908 of the act.
Harvest batch—A specifically identified quantity of medical marijuana plant that is uniform in strain, cultivated utilizing the same growing practices, harvested at the same time and at the same location, and cured under uniform conditions.
Harvest lot—A specifically identified quantity of medical marijuana plant taken from a harvest batch.
Harvested hemp—Plant material, certified as hemp by a Department of Agriculture approved laboratory, obtained directly from a person holding a permit issued by the Department of Agriculture to grow or cultivate hemp under the 3 Pa.C.S. Chapter 15 (relating to controlled plants and noxious weeds) by a grower/processor holding a permit under the act.
Health care medical marijuana organization—A vertically integrated health system approved by the Department to dispense medical marijuana or grow and process medical marijuana, or both, in accordance with a research study under sections 1901—1908 of the act.
Hydroponic nutrient solution—A mixture of water, minerals and essential nutrients without soil used to grow medical marijuana plants.
IRB—Institutional review board—A board, committee, RAC or group designated by an ACRC that reviews and approves the anticipated scope of an approved clinical registrant’s research study involving human subjects under the criteria in 45 CFR 46.111 (relating to criteria for IRB approval of research) and 21 CFR 56.111 (relating to criteria for IRB approval of research).
Identification card—A document issued under section 501 of the act (35 P.S. § 10231.501) that authorizes a patient or caregiver to have access to medical marijuana products under the act.
Immature medical marijuana plant—A rootless, nonflowering part of a medical marijuana plant that is no longer than 12 inches and no wider than 12 inches produced from a cutting, clipping or seedling and that is in a growing container that is no larger than 2 inches wide and 2 inches tall that is sealed on the sides and bottom.
Initial permit application—The document submitted to the Department by an applicant that, if approved, grants a permit to an applicant.
Institution of higher education—A community college, State-owned institution, State-related institution, or private college or university approved by the Department of Education.
Laboratory—A place, establishment or institution within this Commonwealth that has been issued a certificate of accreditation.
Legal guardian—(i) An individual appointed as a guardian of a patient under the laws of the Commonwealth.
(ii) The term does not include an individual who has been appointed a guardian only of a patient’s property.
Limited access area—An area on a site or within a facility where:(i) Immature medical marijuana plants or medical marijuana plants are growing or being processed into medical marijuana.
(ii) Immature medical marijuana plants, medical marijuana plants, medical marijuana or medical marijuana products are being loaded into or out of transport vehicles.
(iii) Seeds, immature medical marijuana plants, medical marijuana plants, medical marijuana or medical marijuana products are packaged for sale or stored.
(iv) Medical marijuana waste is processed, stored or destroyed.
(v) Surveillance system devices are stored or maintained.
Marijuana—(i) All parts of the plant Cannabis sativa L., whether growing or not, the seeds of that plant and resin extracted from any part of the plant, and every compound, manufacture, salt, derivative, mixture or preparation of the plant, its seeds or resin.
(ii) The term does not include the mature stalks of Cannabis sativa L., fiber produced from the stalks, oil or cake made from the seeds of the plant, any other compound, manufacture, salt or derivative, mixture or preparation of the mature stalks.
(iii) The term does not include synthetic cannabinoids as defined in section 4(1)(vii) of The Controlled Substance, Drug, Device and Cosmetic Act (35 P.S. § 780-104(1)(vii)).
Medical board—Either of the following:(i) The State Board of Medicine as defined in section 2 of the Medical Practice Act of 1985 (63 P.S. § 422.2).
(ii) The State Board of Osteopathic Medicine as defined in section 2 of the Osteopathic Medical Practice Act (63 P.S. § 271.2).
Medical marijuana—Marijuana for certified medical use, limited to the following forms:(i) Pill.
(ii) Oil.
(iii) Topical forms, including gels, creams or ointments.
(iv) A form medically appropriate for administration by vaporization or nebulization, including dry leaf or plant form for administration by vaporization.
(v) Tincture.
(vi) Liquid.
Medical marijuana cardholder—An adult patient or caregiver who possesses a valid identification card.
Medical marijuana container—A sealed, traceable, food compliant, tamper resistant, tamper evident container used for the purpose of containment of packaged medical marijuana products being transported from a grower/processor to a medical marijuana organization or an approved laboratory.
Medical marijuana extract—A substance obtained by separating cannabinoids from a medical marijuana plant by a mechanical, chemical or other process.
Medical marijuana organization—(i) A dispensary or a grower/processor.
(ii) The term does not include a health care medical marijuana organization under sections 1901—1908 of the act.
Medical marijuana patient authorization letter—A document issued by the Department under § 1191a.32 (relating to medical marijuana patient authorization letters).
Medical marijuana plant—A plant which is greater than 12 vertical inches in height from where the base of the stalk emerges from the growth medium to the tallest point of the plant, or greater than 12 horizontal inches in width from the end of one branch to the end of another branch.
Medical marijuana product—The final form and dosage of medical marijuana that is grown, processed, produced, sealed, labeled and tested by a grower/processor and sold to a dispensary.
Medical Marijuana Program—The program authorized under the act and implemented by the Department.
Medical marijuana unit—An amount of medical marijuana equivalent to 3.5 grams of dry leaf, 1 gram of concentrate or 100 milligrams of THC infused into a pill, capsule, oil, liquid, tincture or topical form.
Medical marijuana waste—(i) Solid, liquid, semi-solid or contained gaseous materials that are generated by a grower/processor or an approved laboratory.
(ii) The term includes:
(A) Unused, surplus, returned, recalled, contaminated or expired medical marijuana, except as described in subsection (iii).
(B) Medical marijuana plant material that is not used in the growing, harvesting or processing of medical marijuana, including flowers, stems, trim, leaves, seeds, dead medical marijuana plants, dead immature medical marijuana plants, unused medical marijuana plant parts, unused immature medical marijuana plant parts or roots.
(C) Spent hydroponic nutrient solution.
(D) Unused containers for growing immature medical marijuana plants or medical marijuana plants or for use in the growing and processing of medical marijuana.
(E) Unused fertilizers and pesticides.
(F) Unused excipients.
(G) Wastewater.
(iii) The term does not include medical marijuana products erroneously delivered to a dispensary other than the dispensary intended for sale, provided that the packaging remains unopened, with tamper-evident seals intact, and the medical marijuana products are immediately delivered to the correct dispensary.
Medical professional—A physician, pharmacist, physician assistant or certified registered nurse practitioner employed by a dispensary.
Minor patient—A patient who is under 18 years of age.
Minority-owned business—The term as defined in 74 Pa.C.S. § 303(b).
Municipal waste—The term as defined in section 103 of the Solid Waste Management Act (35 P.S. § 6018.103).
Municipality—A county, city, borough, incorporated town or township, or any similar general-purpose unit of government which shall hereafter be created by the General Assembly.
Nebulization—The generation of medical marijuana products in the form of fine spray for medicinal inhalation.
Nutrient—The essential elements and compounds necessary for the growth, metabolism and development of medical marijuana plants.
Nutrient practice—The use by a grower/processor of essential elements and compounds necessary for the growth, metabolism and development of seeds, immature medical marijuana plants or medical marijuana plants.
Office—The Department’s Office of Medical Marijuana.
Operational—The time at which the Department determines that a medical marijuana organization is ready, willing and able to properly carry on the activity for which a permit has been issued under this part, including the implementation of an electronic tracking system.
Operator—An individual who directly oversees or manages the day-to-day business functions for an applicant or permittee and has the ability to direct employee activities onsite and offsite or within a facility for which a permit is sought or has been issued under this part.
Parent—The biological, natural or adoptive mother or father of a patient.
Patient—An individual who meets all of the following qualifications:(i) Has a serious medical condition.
(ii) Has met the requirements for certification under the act.
(iii) Is a resident of this Commonwealth.
Patient and caregiver registry—A list of patients and caregivers established and maintained by the Department.
Patient certification—The document issued by a practitioner under § 1181a.27 (relating to issuing patient certifications) certifying that a patient has one or more serious medical conditions.
Patient consultation—A complete examination of a patient and the patient’s health care records at the time a patient certification is issued by a practitioner.
Permit—An authorization issued by the Department to a medical marijuana organization to conduct activities authorized under the act.
Permittee—A person who has been issued an authorization to operate as a medical marijuana organization under the act and this part.
Person—A natural person, corporation, foundation, organization, business trust, estate, limited liability company, licensed corporation, trust, partnership, limited liability partnership, association or other form of legal business entity.
Pharmacist—The term as defined in section 2 of the Pharmacy Act (63 P.S. § 390-2).
Physician—The term as defined in section 2 of the Medical Practice Act of 1985 or section 2 of the Osteopathic Medical Practice Act.
Physician assistant—The term as defined in section 2 of the Medical Practice Act of 1985 or section 2 of the Osteopathic Medical Practice Act.
Postharvest plant material—Unfinished plant and plant-derived material, whether fresh, dried, partially dried, frozen or partially frozen, oil, concentrate or similar byproducts derived or processed from medical marijuana or medical marijuana plants.
Practitioner—A physician who is registered with the Department under section 401 of the act (35 P.S. § 10231.401).
Practitioner registry—A list of practitioners established and maintained by the Department.
Prescription Drug Monitoring Program—The Achieving Better Care by Monitoring All Prescriptions Program (ABC-MAP) Act (35 P.S. § § 872.1—872.40).
Principal—An officer, director or person who directly or beneficially owns securities of an applicant or permittee, or a person who has a controlling interest in an applicant or permittee or who has the ability to elect the majority of the board of directors of an applicant or permittee or otherwise control an applicant or permittee, other than a financial institution.
Process lot—Any amount of a medical marijuana product of the same type and processed using the same medical marijuana extract, standard operating procedures and the same or combination of different harvest lots.
Processing—The compounding or conversion of medical marijuana extract by a grower/processor into a medical marijuana product.
Professional disciplinary action—A disciplinary proceeding taken by the applicable medical board against a practitioner that results in a corrective action or measure.
Publicly traded company—A person other than an individual who:(i) Has a class or series of securities registered under the Securities Exchange Act of 1934 (15 U.S.C. § § 78a—78qq) or on a foreign stock exchange determined by the Department to have similar listing and reporting requirements to exchanges that are regulated under the Securities Exchange Act of 1934.
(ii) Is a registered management company under the Investment Company Act of 1940 (15 U.S.C. § § 80a-1—80a-64).
(iii) Is subject to the reporting obligations imposed by section 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. § 780(d)) by reason of having filed a registration statement which has become effective under the Securities Act of 1933 (15 U.S.C. § § 77a—77aa).
RAC—Research approval committee—A board, committee or group created or designated by an ACRC to review and approve the scope and research protocols of a research program proposed by an approved clinical registrant.
Research—A systematic investigation, including research development, testing and evaluation, designed to develop or contribute to generalizable knowledge.
Research contract—A written agreement between an approved clinical registrant and an ACRC that contains the responsibilities and duties of each party with respect to the research program or research study that the approved clinical registrant and the ACRC intend to conduct under this chapter and under which the ACRC will provide medical advice to the approved clinical registrant regarding, among other areas, patient health and safety, medical applications, and dispensing and management of controlled substances. This term shall include a letter of intent to enter into an agreement for purposes of a clinical registrant application.
Research initiative—A nonpatient investigation not subject to Institutional Review Board or Research Approval Committee approval requirements of a patient-based research program, project or study, conducted by an ACRC and its contracted clinical registrant.
Research program—Research on the therapeutic or palliative efficacy of medical marijuana limited to the serious medical conditions defined by the act and this part.
Research project or study—Other research on medical marijuana or its effectiveness in treating a medical or psychological condition.
Research protocol—A written procedure for conducting a research program, project or study that includes all of the following information:(i) With respect to the investigator:
(A) Name and address.
(B) Institutional affiliation.
(C) Qualifications, including a curriculum vitae and list of publications, if any.
(ii) With respect to the research program, project or study:
(A) Title of the research program, project or study.
(B) Statement of the purpose.
(C) Type of medical marijuana product involved and the amount needed.
(D) Description of the research to be conducted, including the number and type of medical marijuana product, the dosage, the route and method of administration, and the duration of the research program, project or study.
(E) The locations of the dispensaries that will be participating in the research program, project or study.
Sample—Medical marijuana or medical marijuana products collected by an employee of an approved laboratory from a grower/processor facility for testing by the laboratory.
Security—The term as defined in section 102(t) of the Pennsylvania Securities Act of 1972 (70 P.S. § 1-102(t)).
Serious medical condition—The conditions listed in Appendix A (relating to serious medical condition).
Service-disabled—The term as defined in 51 Pa.C.S. § 9601 (relating to definitions).
Service-disabled veteran-owned small business—The term as defined in 51 Pa.C.S. § 9601.
Site—The total area contained within the property line boundaries in which a facility is operated by a medical marijuana organization.
Species—Cannabis sativa, Cannabis indica or a hybrid of the two.
Spent hydroponic nutrient solution—Hydroponic nutrient solution that has been used and can no longer serve the purpose for which it was produced.
Synchronous interaction—A two-way or multiple-way exchange of information between a patient and a health care provider that occurs in real time by means of audio or video conferencing.
THC—Delta-9 tetrahydrocannabinol, CAS number 1972-08-3.
THCA—Tetrahrydrocannabinolic acid, CAS number 23978-85-0.
THCV—Tetrahydrocannabivarin, CAS number 31262-37-0.
Terminal illness—A condition or disease for which the medical prognosis of life expectancy is approximately 1 year or less if the condition or disease runs its normal course.
Terpenes—Naturally occurring hydrocarbons found in essential oil secreted from the marijuana plant.
Test sample—An amount of medical marijuana, medical marijuana products or an amount of soil, growing medium, water or solvents used to grow or process medical marijuana, dust or other particles obtained from the swab of a counter or equipment used in the growing or processing of medical marijuana, or other item used in the growing or processing of medical marijuana in a grower/processor facility taken by an employee of an approved laboratory or an agent of the Department at the request of the Department from a grower/processor facility and provided to an approved laboratory for testing.
Third-party certifying organization—The term as defined in 74 Pa.C.S. § 303(b).
Transport vehicle—A vehicle that meets the requirements of the act and is used to transport seeds, immature medical marijuana plants, medical marijuana plants, medical marijuana and medical marijuana products between medical marijuana organizations or between medical marijuana organizations and an approved laboratory.
Unit—The weight or volume of total usable medical marijuana products, calculated in metric units.
Vaporization—The generation of medical marijuana products in the form of vapor for medicinal inhalation.
Veteran—The term as defined in 51 Pa.C.S. § 9601.
Veteran-owned small business—The term as defined in 51 Pa.C.S. § 9601.
Women-owned business—The term as defined in 74 Pa.C.S. § 303(b).
No part of the information on this site may be reproduced for profit or sold for profit.
This material has been drawn directly from the official Pennsylvania Code full text database. Due to the limitations of HTML or differences in display capabilities of different browsers, this version may differ slightly from the official printed version.
